14th International Conference on Alzheimer's Drug Discovery

This annual Alzheimer's Drug Discovery Foundation conference brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer’s disease and related dementias. OBJECTIVES ● Highlight scientific progress on drug discovery programs aimed at treating Alzheimer’s disease and related dementias. ● Increase networking opportunities for scientists to share information and resources. ● Foster interdisciplinary and public-private partnerships and alliances. TARGET AUDIENCE The 2012 edition of this conference attracted attendees from around the world. Attendees included: ● Academic and industry scientists engaged in drug discovery research for neurodegenerative diseases and CNS ● Business development and licensing professionals ● Alliance management professionals ● Venture capitalists and other investors